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background
There is a paucity of data describing the sustained benefits of lifestyle 
interventions on health behaviors and blood pressure (BP).
methods
We examined the persistence of changes in health habits and BP in 
the ENCORE study, a trial in which 144 overweight individuals with 
above-normal BP were randomized to one of the following 16-week 
interventions: Dietary Approaches to Stop Hypertension (DASH) 
diet  alone (DASH-A), DASH diet plus a behavioral weight manage-
ment intervention (DASH-WM), or Usual Care. Follow-up assessments 
were conducted 8 months after the end of treatment.
results
At 16 weeks, systolic BP was reduced by 16.1 (95% confidence interval 
(CI) = 13.0–19.2) mm Hg in the DASH-WM group, 11.2 (95% CI = 8.1–
14.3) mm Hg in the DASH-A group, and 3.4 (95% CI  =  0.4–6.4) mm 
Hg in the Usual Care group. A decrease in BP persisted for 8 months, 
with systolic BP lower than baseline by 11.7 (95% CI = 8.1–15.3) mm 
Hg in the DASH-WM group, 9.5 (95% CI  =  6.7–12.1) mm Hg in the 
DASH-A group, and 3.9 (95% CI = 0.5–7.3) mm Hg in the Usual Care 
group (P < 0.001 for active treatments vs. Usual Care). DASH-WM sub-
jects lost 8.7 kg during the intervention and remained 6.3 kg lighter 
on follow-up examination. Changes in diet content were sustained 
in both DASH intervention groups. Among those who participated 
in DASH-WM, however, caloric intake was no longer lower, and only 
21% reported still exercising regularly 8 months after completing the 
intervention.
conclusions
Changes in dietary habits, weight, and BP persisted for 8  months 
after completion of the 16-week ENCORE program, with some atten-
uation of the benefits. Additional research is needed to identify effec-
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Lifestyle modifications are recommended as the initial 
treatment for high blood pressure (BP).1–3 Randomized, 
controlled trials have demonstrated that the Dietary 
Approaches to Stop Hypertension (DASH) diet, weight 
loss, and exercise are effective in lowering BP in the short 
term.4–8 However, there is a paucity of data describing the 
persistence of the effects of short-term interventions on 
health behaviors and BP. We recently reported results of a 
trial demonstrating that a 16-week lifestyle modification 
program emphasizing the DASH diet  alone or in combi-
nation with a weight management intervention resulted 
in significant BP lowering and improved cardiovascular 
biomarkers.4 In this paper, we examine the persistence of 
changes in dietary habits, exercise behaviors, body weight, 
and BP 1 year after study enrollment.
MeTHoDs
subjects
Participants were 144 healthy but overweight men and 
women with above-normal BP who were not treated with 
antihypertensive medications. Persons were eligible if they 
were aged >35 years, had a body mass index of 25–39.9 kg/
m2, were sedentary, and had a BP of 130–160/80–99 mm Hg. 
Exclusion criteria included clinical or laboratory evidence of 
cardiac disease, chronic kidney disease, or diabetes.
Design
Details of the ENCORE (Exercise and Nutrition 
Interventions for Cardiovascular Health) study protocol 
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have been described previously.4 The study was approved by 
the institutional review board at Duke University Medical 
Center, and written informed consent was obtained from 
each subject before participation.
Participants were recruited from physician referrals, com-
munity-based screenings, and advertisements. Eligibility was 
established during a series of screening visits that included a 
history and physical examination, measurement of height and 
weight, assessment of dietary content, and determination of 
baseline BP. Participants were then randomized with equal 
probability to 1 of the following 16-week treatment condi-
tions: (i) DASH diet  alone (DASH-A); (ii) DASH diet plus 
behavioral weight management (DASH-WM); or (iii) Usual 
Care. Measurements of weight, dietary content, and BP were 
repeated at the conclusion of the intervention. None of the 
treatment conditions included a maintenance phase, although 
DASH-A and Usual Care subjects were provided informa-
tion about behavioral strategies to lose weight. Participants 
returned for a follow-up visit 1  year after enrollment 
(8 months after completion of the intervention), at which time 
BP, weight, dietary content, exercise habits, antihypertensive 
medications, and cardiovascular events were assessed.
Measurements
BP was measured by a trained examiner blinded to the 
study group assignment using a mercury sphygmomanom-
eter and adhering to the guidelines for proper BP measure-
ment technique described in the Seventh Report of the Joint 
National Committee on Prevention, Detection, Evaluation, 
and Treatment of High Blood Pressure.1 After the partici-
pant rested for 5 minutes in the seated position, 4 readings 
were acquired, each 2 minutes apart, and the results were 
averaged. Measurements were acquired on 4 screening ses-
sions over a 3–4-week period for baseline values, on 4 visits 
to the research clinic during the final week of the interven-
tion phase, and on a single follow-up visit 8  months after 
completion of the intervention.
Body weight was measured in kilograms using a cali-
brated digital scale. Dietary intake patterns were assessed 
using a 4-day food diary,9 and data were analyzed using 
Food Processor SQL Edition software, version 10.3 (ESHA 
Research, Salem, OR). Physical activity was determined on 
the follow-up visit by self-report; adherence to a program 
of regular exercise was defined as exercise ≥3 times a week 
at an intensity of ≥4 on a scale of 1–5. Medication use and 
interval history of cardiovascular events were assessed by 
questionnaire.
interventions
After randomization, participants entered a 2-week con-
trolled feeding period during which they were provided 
meals according to their assigned dietary patterns (DASH 
diet, reduced calorie DASH diet, or control diet). Additional 
details of the study diets are described in a previous publica-
tion.4 After the initial 2 weeks of controlled feeding, partici-
pants were instructed to maintain the DASH diet either with 
(DASH-WM) or without (DASH-A) weight loss.
DASH diet alone. Participants in the DASH-A condition 
met weekly with the study nutritionist in small group sessions 
to discuss the DASH diet and receive feedback on their adher-
ence to the diet. The goal of the weekly sessions was to assist 
participants in learning how to buy and prepare the appropri-
ate foods, to enhance their motivation to choose to eat those 
foods, and to overcome obstacles to following the diet.
DASH plus weight management. Participants in the 
DASH-WM condition received the same instruction in the 
DASH diet as the DASH-A group, but their small group ses-
sions also included a weekly cognitive behavioral weight 
loss intervention and supervised exercise sessions 3 times 
per week. The cognitive behavioral weight loss intervention 
was based on cognitive behavioral strategies10 and included 
appetite awareness training, a self-monitoring strategy in 
which individuals learn to identify internal cues of moderate 
hunger and fullness and to use these cues to guide their eat-
ing behavior.11 The supervised exercise routine consisted of 
10 minutes of warm-up exercises, 30 minutes of biking and/
or walking or jogging at 70%–85% of the initial heart rate 
reserve, and 5 minutes of cool-down exercises.
Usual Care control subjects. Participants in the Usual 
Care condition were asked to maintain their usual dietary 
and exercise habits for the 4 months of the intervention.
statistical analysis
We examined treatment group differences on systolic BP, 
diastolic BP, and weight 1 year after study entry (8 months after 
the intervention ended) using an intent-to-treat analysis with 
mixed repeated measures models with SAS PROC MIXED 
(SAS version 9.2; SAS, Cary, NC). The BP outcomes meas-
ured at 16 weeks and 1 year were modeled as discrete repeated 
measures (with the post-treatment measurement occasions 
specified as a class variable and used in the REPEATED state-
ment in PROC MIXED); predictors included the correspond-
ing baseline BP, age, sex, ethnicity, time, treatment group, body 
weight at baseline, and a time by treatment group interaction 
term. The weight outcome was modeled in similar fashion, 
using 16-week and 1-year weight as repeated measures, with 
age, sex, ethnicity, time, treatment group, weight at baseline, 
and a time by treatment group interaction term as predic-
tors. Continuous variables were centered at their medians, 
with time coded in reverse such that 1 year = 0. The contrasts 
of primary interest were (i) active treatments (DASH-A and 
DASH-WL) vs. Usual Care and (ii) DASH-WL vs. DASH-A, 
each evaluated at the 1-year measurement occasion. Because 
subjects in the Usual Care and DASH-A groups were asked to 
maintain their weight during the 16-week intervention, for the 
weight outcome, we used contrasts that compared DASH-WM 
to DASH-A and Usual Care and also DASH-A and Usual Care 
to each other. An important advantage of mixed models is that 
all randomized participants can be included in the analysis 
irrespective of missing data on post-treatment assessments. 
Mixed models have been shown to produce treatment effect 
estimates that are less biased and have narrower confidence 
intervals compared with conventional case-wise deletion or 
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last-observation-carried-forward analyses.12 Thus, the analy-
ses described above included the entire initial cohort of 144 
participants. BP and body weight data were available for 140 
participants at the 16-week measurement occasion (46 in 
DASH-WM, 46 in DASH-A, and 48 in Usual Care) and 124 
participants at the 1-year assessment (42 in DASH-WM, 41 
in DASH-A, and 41 in Usual Care). Models were estimated 
using restricted maximum likelihood. The variance compo-
nents structure was found to be a reasonable assumption for 
the covariance matrix. Assumptions were evaluated for all 
models and found to be reasonably met.
Group differences in dietary component intake at 1 year 
were evaluated using the general linear model, again with 
models adjusted for age, sex, ethnicity, and the baseline 
measure for the relevant outcome variable. Binary exercise 
and medication variables at 1 year were analyzed using logis-
tic regression. As with the primary analyses, contrasts were 
constructed based on the a priori expectation for a given 
outcome variable. In these latter analyses, only participants 
with complete data were included.
resUlTs
Participants
After screening, 144 participants were randomized: 46 
to the DASH-A group, 49 to the DASH-WM condition, 
and 49 to Usual Care. Only 4 subjects (3 from DASH-WM 
and 1 from Usual Care) withdrew during the interven-
tion phase. Sixteen additional subjects (5 from DASH-A, 4 
from DASH-WM, and 7 from Usual Care) did not return 
for the follow-up evaluation at 1 year (Figure 1). Compared 
with those who had complete weight and BP data, subjects 
who dropped out at either 16 weeks or 1 year tended to be 
younger (mean age = 48 vs. 53 years; P= 0.02), but did not 
differ statistically on BP, baseline weight, weight lost during 
the intervention, sex, or ethnicity.
Characteristics of the 144 participants enrolled in the 
trial are shown in Table  1. They were primarily middle 
aged (mean age  =  52 (SD  =  10) years), white (60%), and 
female (67%) and had an average body mass index of 33.1 
(SD = 3.9) kg/m2. The mean clinic BP was 138 (SD = 9)/86 
(SD = 6) mm Hg. The groups were comparable across the 
background demographic and clinical variables (Table 1).
Weight, DasH dietary components, aerobic fitness, and 
blood pressure at 16 weeks
As previously reported,4 participants in DASH-WM lost 
8.7 kg during the treatment period compared with a loss of 
0.3 kg in DASH-A (P < 0.001) and a gain of 0.9 kg in Usual 
Care (P < 0.001). Daily dietary sodium intake was lower, and 
consumption of potassium, magnesium, and calcium was 
greater in DASH-A and DASH-WM than in Usual Care at 16 
weeks (Ps < 0.001). BP was reduced in the DASH-WM group 
by 16.1 (95% confidence interval (CI) = 13.0–19.2)/9.9 (95% 
CI = 8.1–11.6) mm Hg, compared with 11.2 (95% CI = 8.1–
14.3)/7.5 (95% CI  =  5.8–9.3) mm Hg in DASH-A and 3.4 
(95% CI = 0.4–6.4)/3.8 (95% CI = 2.2–5.5) mm Hg in Usual 
Care. Contrasts between all active treatments and Usual Care 
were statistically significant for both systolic BP and diastolic 
BP (Ps < 0.001); similarly, the contrast between DASH-WM 
and DASH-A was statistically significant for both systolic BP 
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144 BP too high/low




Figure 1. Patient flow from initial screening to 1-year follow-up. Abbreviations: DASH-A, Dietary Approaches to Stop Hypertension (DASH) diet alone; 
DASH-WM, DASH diet plus behavioral weight management.
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Weight, DasH dietary components, exercise behaviors, and 
medication use at 1 year
Figure  2 displays the adjusted mean weight and 95% CI 
for each group at the 3 time points. Participants’ average 
body weight at 1 year was 86.7 kg in DASH-WM, 91.9 kg in 
DASH-A, and 91.8 kg in Usual Care (Ps = 0.001 for DASH-WM 
compared with either DASH-A or Usual Care after adjusting 
for baseline weight and demographic characteristics). Those 
in the DASH-WM group were 6.3 kg lighter than at baseline 
(2.4 kg heavier than at 16 weeks), whereas sustained weight 
loss averaged 1.5 kg in DASH-A and 1.6 kg in Usual Care.
Levels of nutrient and caloric intake, self-reported exercise 
frequency, and medication use at 1 year are shown in Table 2. 
Consumption of sodium was lower, and dietary intake of potas-
sium, calcium, and magnesium was greater in the 2 DASH 
groups compared with the Usual Care group. There were no sig-
nificant differences in daily caloric intake between participants 
in DASH-WM and the other 2 groups. Self-reported intake in 
the DASH-WM group increased by about 150 calories between 
completion of the intervention and the follow-up visit.
At follow-up only about 1 in 5 subjects who had completed 
the DASH-WM intervention, which emphasized physical 
activity and weight loss, reported still exercising ≥3 times 
weekly. Only 16 patients (13%)—5 (12%) in DASH-WM, 5 
(13%) in DASH-A, and 6 (16%) in Usual Care—were pre-
scribed antihypertensive medications 1  year after study 
enrollment. No subjects experienced adverse cardiovascular 
events over the year of observation.
Blood pressure at 1 year
Systolic BP at 1  year was significantly lower in partici-
pants in the active treatment groups compared with those 
randomized to Usual Care (difference = −6.7 mm Hg; 95% 
CI = −10.6 to −2.9; P < 0.001) (Figure 3a), with no significant 
difference between DASH-WM and DASH-A participants 
(difference = −2.2 mm Hg; 95% CI = −.6.7 to 2.3; P = 0.33). 
Table 1. Baseline characteristics of sample
Characteristic No. DASH-WM (n = 49) DASH-A (n = 46) Usual Care (n = 49) All (n = 144)
Age, y 144 52.3 (10) 51.8 (10) 51.8 (9) 52.0 (10)
Sex: female 144 69% (34) 63% (29) 69% (34) 67% (97)
Ethnicity 144
 White 69% (34) 50% (23) 59% (29) 60% (56)
 Black 31% (15) 48% (22) 39% (19) 39% (86)
 Asian 0% (0) 2% (1) 2% (1) 1% (2)
 Hispanic 144 4% (2) 0% (0) 6% (3) 3% (5)
Level of education 143
 High school 31% (15) 30% (14) 42% (20) 34% (49)
 Some college 8% (4) 9% (4) 14% (7) 11% (15)
 Completed college 29% (14) 30% (14) 18% (9) 22% (32)
 Graduate school 20% (10) 28% (13) 20% (10) 24% (34)
 Other 12% (6) 13% (6) 2% (1) 9% (13)
Household income per year 123
 < $20,000 10% (5) 13% (6) 20% (10) 15% (21)
 $20,000–$49,999 14% (7) 4% (2) 8% (4) 11% (13)
 $50,000–$99,999 6% (3) 13% (6) 18% (9) 15% (18)
 >$100,000 55% (27) 50% (23) 43% (21) 49% (71)
Weight, kg 144 93.9(14) 93.0 (14) 92.6 (15) 93.1 (14.1)
BMI, kg/m2 144 33.5 (4.4) 32.8 (3.4) 33.0 (3.9) 33.1 (3.9)
Peak VO2 142 23.4 (6.2) 23.8 (6.5) 23.2 (5.8) 23.4 (6.2)
Systolic BP, mm Hg 144 139 (8) 138 (9) 138 (9) 138 (9)
Diastolic BP, mm Hg 144 85 (7) 86 (6) 86 (6) 86 (6)
Current smoker 144 4% (2) 7% (3) 10% (5) 7% (10)
Diabetes 144 2% (1) 0% (0) 0% (0) <1% (1)
Hyperlipidemia 144 33% (16) 22% (10) 33% (16) 29% (42)
Values are mean (SD) for continuous variables and % (No.) for categorical variables.
Abbreviations: BMI, body mass index; BP, blood pressure; DASH-A, Dietary Approaches to Stop Hypertension (DASH) diet alone; DASH-WM, 
DASH diet plus behavioral weight management; VO2, exercise oxygen consumption.
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The adjusted 1-year means derived from the mixed model 
were 126.6 (95% CI = 123.5–129.8) mm Hg in DASH-WM, 
128.9 (95% CI = 125.7–132.0) mm Hg in DASH-A, and 134.5 
(95% CI = 131.3–137.6) mm Hg in Usual Care. Examining 
change at 1  year compared with baseline, systolic BP was 
reduced 11.7 (95% CI = 8.1–15.3) mm Hg in the DASH-WM, 
9.5 (95% CI = 6.7–12.1) mm Hg in DASH-A, and 3.9 (95% 
CI = 0.5–7.3) mm Hg in Usual Care. In the mixed model for 
diastolic BP the groups did not differ at 1 year (Figure 3b). 
Reanalyzing the data excluding the 16 patients who were 
prescribed antihypertensive medication after randomization 
did not alter the conclusions regarding the treatment effect 
at 1 year for either systolic BP or diastolic BP.
DisCUssion
In our study of overweight, sedentary men and women 
with high BP, a structured, 16-week lifestyle intervention, 
consisting of the DASH diet with or without a weight loss 
and exercise component, resulted in significant decreases in 
BP compared with a Usual Care control group. In both DASH 
diet conditions, a lower systolic BP persisted for 8 months. 
There was, however, some attenuation of the weight loss and 
BP benefits of the DASH-WM intervention during the fol-
low-up period. The attenuation of weight loss was likely due 
to both small increases in caloric intake and decreased energy 
























Figure 2. Mean weight in kilograms for each treatment group before and after 16 weeks of treatment and 1 year after study entry. Baseline values are 
adjusted for age, race, and sex. Values for 4 and 12 months are derived from the mixed model and are adjusted for age, race, sex, and baseline body weight. 
Error bars represent 95% confidence intervals. The narrow confidence intervals for the 4 and 12 month values reflect the adjustment of these values for baseline 
body weight. Abbreviations: DASH-A, Dietary Approaches to Stop Hypertension (DASH) diet alone; DASH-WM, DASH diet plus behavioral weight management.











Treatment vs. Usual Care DASH-WM vs. DASH-A
Sodium, mg/d 2,324 (712) 2,031 (1,126) 2,803 (849) 2,436 (1,132) 0.002 0.107
Potassium, mg/d 3,069 (1,211) 3,217 (1,834) 2,702 (1,144) 2,953 (1,307) <0.001 0.481
Calcium, mg/d 906 (450) 937 (380) 828 (431) 902 (442) 0.041 0.438
Magnesium, mg/d 362 (155) 337 (210) 299 (130) 317 (151) <0.001 0.598
BP medication 12% (5) 12% (5) 15% (6) 13% (16) 0.968 0.687
DASH-WM vs 
DASH-A
DASH-WM vs Usual Care
Total calories, kcal/d 1,806 (550) 1,772 (653) 1,873 (669) 1,810 (652) 0.498 0.569
Exercising ≥ 3×/week 21% (9) 22% (9) 7% (3) 17% (21) 0.954 0.242
Values are mean (SD) for continuous variables and (%) No. for categorical variables.
Abbreviations: BP, blood pressure; DASH-A, Dietary Approaches to Stop Hypertension (DASH) diet  alone; DASH-WM, DASH diet plus 
behavioral weight management.
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both DASH groups. However, among those who participated 
in the weight management condition, caloric intake was no 
longer lower and only about 20% reported still exercising 
regularly 8 months after completing the intervention.
Although there is substantial evidence documenting 
the efficacy of the DASH diet, weight loss, and exercise in 
lowering BP, there is little information on the persistence 
of benefits of life-style interventions on BP. Several studies 
have examined the sustained effects of weight loss and diet 
interventions that have included a prolonged maintenance 
phase. The Trials of Hypertension Prevention (TOHP) II 
tested interventions to promote weight loss, dietary sodium 
reduction, and their combination in untreated, overweight 
adults with high-normal BP over a 3- to 4-year period.13,14 
Over the 6 months of the initial intensive intervention, the 
weight loss and combined groups experienced losses of 
more than 4 kg, and the estimated main effect of the sodium 















































Figure 3. Mean (a) systolic and (b) diastolic BP for each treatment group before and after 16 weeks of treatment and 1 year after study entry. Baseline 
values are adjusted for age, race, and sex. Values for 4 and 12 months are derived from the mixed model and are adjusted for age, race, sex, baseline 
body weight, and baseline BP. Error bars represent 95% confidence intervals. Abbreviations: BP, blood pressure; DASH-A, Dietary Approaches to Stop 
Hypertension (DASH) diet alone; DASH-WM, DASH diet plus behavioral weight management.
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were associated with BP reductions of 2.4/2.0 mm Hg attrib-
utable to weight loss and 1.6/0.8 mm Hg for sodium reduc-
tion. Between 6 and 36 months, the net changes in sodium 
excretion, weight, and BP diminished by about one-fourth 
for sodium excretion, one-half for weight, and two-thirds for 
BP. Trial of Nonpharmacologic Interventions in the Elderly 
(TONE) was a 4-center randomized trial to test whether 
weight loss, reduced sodium intake, or both could main-
tain BP control after withdrawal of antihypertensive drug 
therapy.15,16 At a median of 8 months after discontinuation 
of the intervention, weight loss from baseline remained 
somewhat greater (−3.9 kg) in the weight intervention group 
than in the group not assigned to weight loss (−2.2 kg), but 
this difference was no longer statistically significant. In con-
trast, significant differences in 24-hour urine sodium excre-
tion persisted throughout the extended follow-up. There 
was a long-term effect of the intervention on blood pres-
sure; 48  months after discontinuation of contact between 
participants and the clinical center, 23% of the combined 
intervention group vs. 7% in the Usual Care group remained 
off medication. The weight loss results from the TOHP and 
TONE trials reflect outcomes from other high-intensity 
counseling studies—a reduction in body weight may persist 
for up to 72 months but is significantly attenuated.17–21 As in 
our study, desirable changes in dietary content in TOHP and 
in TONE were more persistent than weight loss.
Exercise was an important component of our DASH diet 
and weight management intervention. Although adherence 
with the 16-week exercise program was high, 8 months later 
only 21% of subjects were engaging in high-intensity aerobic 
physical activity ≥3 times per week. In general, short-term 
trials examining the effects of exercise on BP have demon-
strated more marked reductions than longer-term studies, 
perhaps reflecting better adherence to the exercise inter-
vention in the short-term studies, many of which included 
supervised exercise programs.22 Decreased adherence to an 
exercise intervention over time has also been demonstrated 
in individual trials.23 Adherence to a program of regular 
physical activity may be key to the long-term persistence 
of weight loss and the associated lower blood pressure after 
completion of a lifestyle invention program.24–27
The main limitation of this follow-up study is the lack of 
1-year data for 20 of the 144 subjects who enrolled in the 
trial. The duration of follow-up was relatively short, and 
longer-term data would be valuable in assessing the persis-
tence of benefits from our lifestyle intervention. Patterns of 
dietary intake were assessed by a 4-day food diary, a method 
that is well-validated but nonetheless prone to some bias.28 
Similarly, physical activity can be difficult to measure by self-
report because of the episodic nature of recreational exercise 
and the subjectivity of assessments of exercise intensity. Our 
research was conducted in well-educated and highly moti-
vated individuals who volunteered for a clinical study, and 
the results may not be generalizable to all obese, sedentary 
individuals with high BP.
Our analysis demonstrated that a clinically meaningful 
reduction in BP persisted for 8  months after completion 
of structured lifestyle intervention programs emphasiz-
ing the DASH diet, with some attenuation of the BP and 
weight loss benefits in the group with an exercise and weight 
management component. The greater difficulty experienced 
by our subjects in maintaining lower caloric intake than in 
maintaining changes in food type suggests that weight loss 
interventions need to focus even more on ways to prevent 
the gradual upward drift to pretreatment levels of energy 
consumption. Changes in the types of food regularly con-
sumed may be more obvious to patients than relatively small 
increments in quantity and may reflect the development of 
preferences for healthier foods. Future studies may need 
to place greater emphasis on specific strategies to enhance 
feelings of satiety so that patients are better able to main-
tain the reductions in calorie intake that they achieve dur-
ing a weight loss intervention. Furthermore, development of 
strategies to promptly identify patients who are not main-
taining lifestyle changes, including regular physical activity, 
may be useful; these individuals may need tailored help in 
getting back on track. The use of personal digital devices 
can be effective in promoting lifestyle change, and mobile 
technology may prove particularly useful in promoting the 
maintenance of healthy exercise and dietary habits over time 
when the accountability and support provided by an active 
intervention is no longer available.29
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